Topic: Case Management
Judge William H. Orrick held the Initial Status Conference for the Juul MDL on Friday, November 8th. Prior to that conference he stated that he had a “sense of urgency in moving this case forward. The allegations are very serious and raise significant public health concerns. My expectation is that all parties share this sense […]
Juul recently announced the departure of four senior executives, Chief Marketing Officer Craig Brommer, Chief Finance Officer Tim Danaher, Chief Administrative Officer Ashley Gould and Senior Vice President of Advanced Technology David Foster. In addition, Juul will be laying off approximately 500 people, or about 10% to 15% of its workforce, by the end of […]
Earlier this week a Philadelphia jury awarded Tracy Reed-Brown over $33 million in her IVC filter case against Rex Medical LP. The award included more than $30 million in punitive damages, in addition to compensation for medical expenses and pain and suffering. Ms. Reed-Brown was implanted with an Option Retrievable Inferior Vena Cava Filter System […]
On October 25th Judge William Orrick issued Case Management Order No. 1 in the JUUL litigation consolidated in his court in the Northern District of California. The Order relates to an initial census, a concept also adopted by Judge M. Casey Rogers of the Northern District of Florida, who is handling the MDL relating to […]
Last week a jury in Philadelphia hit Johnson & Johnson and its Janssen Pharmaceuticals subsidiary with an $8 billion punitive damages verdict in a Risperdal trial. Nicholas Murray’s lawsuit alleged that, after being given Risperdal in 2003 at age nine for symptoms of autism, he grew breast tissue, a condition known as gynecomastia. J&J was […]
After a two-week trial in New Orleans, the jury in the first Taxotere bellwether trial delivered a defense verdict. There are approximately 11,000 claims in the multi-district litigation against manufacturer Sanofi Aventis and other defendants alleging the chemotherapy drug Taxotere (docetaxel) caused permanent alopecia. Barbara Earnest, who was diagnosed with breast cancer in 2011, underwent […]
According to a recent FDA announcement, a probable human carcinogen has been found in some ranitidine heartburn medications, including brand name Zantac, and the FDA is investigating the possible source of contamination. The substance is NDMA (N-Nitrosodimethylamine), the same contaminant that lead to recalls of blood pressure and heart failure medications such as Valsartan over […]
Amid an increasing number of reports of vaping-related illnesses and deaths, Juul announced that Kevin Burns has stepped down as CEO and will be replaced by K.C. Crosthwaite, a former executive at Altria, which owns a 35% stake in Juul, who has previously served as an observer to Juul Labs Board of Directors. According to […]
There have been a number of developments in the wake of last week’s tentative settlement of over 2,000 lawsuits filed by a number of municipal governments and states in federal court in Cleveland against a number of defendants, including Purdue Pharma and its owners, the Sackler family. Under the terms of the settlement, in addition […]
Every day seems to bring new developments in the Juul story, with none of them good for Juul. On September 9, the U.S. Food and Drug administration issued a warning letter to Kevin Burns, the CEO of e-cigarette manufacturer JUUL Labs, Inc., for allegedly marketing the Juul device as a “modified risk tobacco product” without […]
